Akademik Veri Yönetim Sistemi
Tezin Türü: Doktora
Tezin Yürütüldüğü Kurum: Orta Doğu Teknik Üniversitesi, Fen Edebiyat Fakültesi, Biyolojik Bilimler Bölümü, Türkiye
Tezin Onay Tarihi: 2009
Öğrenci: TUĞBA TÜMER
Danışman: ORHAN ADALI
Özet:Thiopurine methyltransferase (TPMT) risk alleles (mainly *2,*3B, *3C and *3A) are the major determinants of interindividual differences in the severe toxicity or efficacy of 6-mercaptopurine (6MP) during the treatment of childhood acute lymphoblastic leukemia (ALL). The frequencies of these risk alleles, known to functionally impair TPMT activity, were investigated among 167children with ALL and 206 healthy adult controls in Turkish population by using allele specific PCR and PCRRFLP methods. TPMT*3A and TPMT*3C were the only deficiency alleles detected in Turkish population with an allele frequency of 0.5% for both. The total frequency of mutant TPMT alleles in Turkish population (1.0%) was found to be significantly lower than those of other Caucasian populations (5.3-7.0%), but it was found to be very similar to Kazak population (1.2%) which is also Caucasian in ethnic origin. v In the patient group, two individuals were found to be heterozygote for *3C and *3A allele. One individual was homozygous mutant (*3B/*3C). In this study, the clinical histories of the patients with TPMT defects were examined retrospectively from hospital records. The patients with heterozygous or homozygous mutant genotypes had systematically developed severe neutropenia, infection and some other specific conditions (like lesions around mouth, oral herpes and high fever) when they were administered with 6MP during the therapy. This study provides the first data on the frequency of common TPMT risk alleles in the Turkish population, based on analysis of pediatric patients with ALL. The results would contribute valuable information to the public health, as more clinicians and patients become aware of the importance of TPMT polymorphisms, less patients will suffer from 6MP related adverse effects. In addition, in this study two genes EPHX1-microsomal epoxide hydrolase (exon 3 and exon 4 polymorphisms) and SULT1A1*2 variant – sulfotransferase 1A1, either alone or in combination were investigated as risk modifiers in the development of childhood acute lymphoblastic leukemia due to their dual role (activation/detoxification) in the metabolism of various carcinogens. Also interactions of these polymorphisms with non-genetic risk factors (parental smoking exposure and parental age at conception) were investigated. The conclusion inferred from results was that only genetically reduced EPHX1 activity (homozygous mutant genotype for EPHX1 exon 3 polymorphism and some specific genotype combinations with exon 4 polymorphism) was found to be significantly associated with the risk of childhood ALL.